Producers guaranteed to recoup their spring parasite control investment.
Merial will continue the IVOMEC® (ivermectin) Spring Challenge for the fifth year based on the success of the program for cattle producers. Cattle prices are up, but so are production costs, and producers are feeling the strain on the profit outlook this year. To help promote greater profits and optimize herd health in 2012, Merial will help to take on some of the production risks. Producers will benefit from taking advantage of the IVOMEC Challenge with a risk-free way to ensure spring parasite control pays.
To participate, producers simply need to use any IVOMEC Brand Product on both their cows and calves in the spring. At weaning, if the improved 205-day adjusted weight versus the 2011 weight does not cover the purchase price of the IVOMEC Brand Product used in the spring, Merial will provide an equal number of doses of any IVOMEC Brand Product for fall.
“Merial recognizes that in a tight economy, it’s difficult to justify input costs if you aren’t sure you are getting enough return, but nothing pays off like parasite control in the spring,” says Joe Dedrickson, DVM, Ph.D., Director, Field Veterinary Services, Merial. “The goal is for producers to see a financial gain from their parasite control investment. Because we have confidence in our products, we are willing to back them so that if improvements aren’t achieved, producers won’t risk a profit loss on treatment expenses.”
When combined with good animal husbandry protocols, spring parasite treatments in cow/calf herds have been proven to increase weaning weights and reproductive performance.1-3 In fact, studies going back 25 years have shown a statistically significant increase in weaning weights when cows and calves were treated for parasites in the spring with IVOMEC Brand Products.1,2
“That gain alone will cover the cost of using an IVOMEC Brand Product in the spring,” Dr. Dedrickson says. “There are a lot of variables that can rob producers of production and profits. But between the proven results of spring parasite treatment and the promise of the IVOMEC Challenge, we are certain producers won’t lose money on this input.”
Iowa State University research results show that parasite control tops the list of the most economically rewarding cow/calf pharmaceutical practices. Not controlling parasites can negatively impact a cattle producer’s breakeven by up to $201 per head.4 Even if the return for the average herd is only $20 per head, the impact is still significant when most producers see approximately $105 income per cow.5
Regardless of all of the uncertainty in the cattle business, one thing remains true — cattle producers can trust all four proven formulations of IVOMEC Brand Products.
“Producers can’t afford to take chances with a health practice such as parasite control,” says Dr. Dedrickson. “By choosing a product they can trust, such as an IVOMEC Brand Product that is backed by a 100% Product Satisfaction Guarantee, producers can help protect both their cattle and pocketbook.”
For more information, producers should contact their local Merial sales representative or visit www.merial.com.
IMPORTANT SAFETY INFORMATION:
IVOMEC Plus (ivermectin/clorsulon): Do not treat cattle within 49 days of slaughter. Do not use in dairy cattle of breeding age or in veal calves. IVOMEC (ivermectin) Pour-On: Do not treat cattle within 48 days of slaughter. Do not use in dairy cattle of breeding age or in veal calves. IVOMEC (ivermectin) 1% Injection for Cattle and Swine: Do not treat cattle within 35 days of slaughter. Do not use in dairy cattle of breeding age or in veal calves. Do not treat swine within 18 days of slaughter. IVOMEC EPRINEX® (eprinomectin) Pour-On for Beef and Dairy: No meat or milk withdrawal is required when used according to label. All IVOMEC Brand Products: Do not use in other animal species not on the label as severe adverse reactions, including fatalities in dogs, may result.
Merial is a world-leading, innovation-driven animal health company, providing a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. Merial employs approximately 5,600 people and operates in more than 150 countries worldwide. Its 2011 sales were more than $2.8 billion. Merial is a Sanofi company.
1 Wohlgemuth K, et al. Relationship between weaning weights of North Dakota beef calves and treatment of their dams with ivermectin. Agri-Practice. 1988:23-26.
2 Ciordia H, et al. Effect of ivermectin on performance of beef cattle on Georgia pastures. Am J Vet Res. 1984;45:2455-2457.
3 Holste JE, et al. Reproductive performance of beef cows treated with ivermectin before calving. Mod Vet Prac. 1986:462-464.
4 Lawrence JD, Ibarburu MA. Economic Analysis of Pharmaceutical Technologies in Modern Beef Production in a Bioeconomy Era. 2009 Iowa State University.
5 Cattle Fax 2007, Cow-Calf Budget.